Global Precision Cancer Tests Market Growth (Status and Outlook) 2025-2031

According to this study, the global Precision Cancer Tests market size will reach US$ million by 2031.

Precision cancer tests encompass imaging and in vitro diagnostic products and procedures that directly detect malignancies in patient samples or in the patients themselves.

United States market for Precision Cancer Tests is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Precision Cancer Tests is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Precision Cancer Tests is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Precision Cancer Tests players cover Abbott, BD, Bio-Rad, Cynvenio Biosystems, Foundation Medicine, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the “Precision Cancer Tests Industry Forecast” looks at past sales and reviews total world Precision Cancer Tests sales in 2024, providing a comprehensive analysis by region and market sector of projected Precision Cancer Tests sales for 2025 through 2031. With Precision Cancer Tests sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Precision Cancer Tests industry.

This Insight Report provides a comprehensive analysis of the global Precision Cancer Tests landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Precision Cancer Tests portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Precision Cancer Tests market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Precision Cancer Tests and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Precision Cancer Tests.

This report presents a comprehensive overview, market shares, and growth opportunities of Precision Cancer Tests market by product type, application, key players and key regions and countries.

Segmentation by Type:
Imaging
In Vitro Diagnostic
Others

Segmentation by Application:
Cancer Research Centers
Cancer Hospital
Surgical Centers
Clinics
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Abbott
BD
Bio-Rad
Cynvenio Biosystems
Foundation Medicine
Genomic Health
Illumina
Myriad Genetics
NanoString Technologies
QIAGEN
Randox Laboratories
Roche
Philips
Thermo Fisher Scientific

Please note: The report will take approximately 2 business days to prepare and deliver. Show more